Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s)
- PMID: 22019747
Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s)
Abstract
Aim: Adipose tissue is now regarded as a source of proinflammatory mediators which may contribute to vascular injury, insulin resistance (IR), and atherogenesis, however, some of them have a protective role against vascular inflammation and/or IR; namely adiponectin and nitric oxide (NO). Adiponectin is a fat derived hormone, which enhances insulin sensitivity. In experimental studies adiponectin was shown to have anti-atherogenic properties by suppressing endothelial expression of adhesion molecules as endothelial-selectin (E-selectin) and inflammatory cytokines as high-sensitivity C-reactive protein (hsCRP), interleukin-1β (IL-1β), and monocyte chemotactic protein-1 (MCP-1). Therefore, the aim of the study was to evaluate plasma adiponectin, E-selectin, hsCRP, IL-1β, and MCP-1 concentrations in obese patients with and without coronary heart disease (CHD) having type 2 diabetes mellitus (DM) and evaluation of their relationship with selected anthropometric, biochemical, and clinical parameters.
Methods: The study group consisted of (N.=70) males, 20 of which served as healthy non-obese controls (group I) (mean age 38.5±3.7 years; mean BMI 28±1.2 kg/m2). Patients enrolled in the study were classified into the following groups: type 2 DM obese subjects without CHD (group II) (N.=25) (mean age 42.2±3 years; mean BMI 32.1±1.4 kg/m2) and type 2 DM obese subjects with CHD (group III) (N.=25) (mean age 40.6±3 years; mean BMI 31.5±1.2 kg/m2). Glucose and insulin estimation was performed and insulin resistance index (HOMA-IR) was calculated. In the fasting state, the plasma HbA1c, adiponectin, E-selectin, in comparison to hsCRP, IL-1β, MCP-1, and lipid parameters were estimated.
Results: FBG, HbA 1c %, lipids, insulin, MDA, NO, hsCRP, IL-?, MCP-1, Adiponectin as well as E-selectin concentration were significantly different in patients with type 2 DM and CHD in comparison to patients without CHD and moreover, the healthy control group (P=0.01). There was a significant negative correlation between adiponectin and E-selectin (r=-0.642; P=0.0001).
Conclusion: Our study supports the hypothesis that decreased level of adipokine(s), together with increased oxidative stress, pro-inflammatory marker(s) as well as endothelial adhesion molecule(s) contributes to the complex process of atherosclerosis in type 2 diabetic obese patients that may lead eventually to CHD.
Comment in
-
Adipokines and vascular risk in type 2 diabetes mellitus.Angiology. 2011 Nov;62(8):601-4. doi: 10.1177/0003319711409201. Angiology. 2011. PMID: 21990548 No abstract available.
Similar articles
-
Adiponectin and sE-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease.Angiology. 2012 Feb;63(2):96-102. doi: 10.1177/0003319711408587. Epub 2011 May 20. Angiology. 2012. PMID: 21602254
-
Plasma adiponectin and E-selectin concentrations in patients with coronary heart disease and newly diagnosed disturbances of glucose metabolism.Adv Med Sci. 2006;51:94-7. Adv Med Sci. 2006. PMID: 17357284
-
Adiponectin and pro-inflammatory cytokines in obese diabetic boys.Indian Pediatr. 2011 Oct;48(10):815-6. Indian Pediatr. 2011. PMID: 22080689
-
Recent advances in the relationship between obesity, inflammation, and insulin resistance.Eur Cytokine Netw. 2006 Mar;17(1):4-12. Eur Cytokine Netw. 2006. PMID: 16613757 Review.
-
Inflammation and type 2 diabetes.Diabetes Metab. 2012 Jun;38(3):183-91. doi: 10.1016/j.diabet.2011.11.006. Epub 2012 Jan 16. Diabetes Metab. 2012. PMID: 22252015 Review.
Cited by
-
Inflammatory biomarkers in atherosclerosis: pentraxin 3 can become a novel marker of plaque vulnerability.PLoS One. 2014 Jun 17;9(6):e100045. doi: 10.1371/journal.pone.0100045. eCollection 2014. PLoS One. 2014. PMID: 24936646 Free PMC article.
-
Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease.Cardiovasc Diabetol. 2012 Jun 6;11:60. doi: 10.1186/1475-2840-11-60. Cardiovasc Diabetol. 2012. PMID: 22672501 Free PMC article. Clinical Trial.
-
Relationship of adiponectin to markers of oxidative stress in type 2 diabetic patients: influence of incipient diabetes-associated kidney disease.Int Urol Nephrol. 2015 Jul;47(7):1173-80. doi: 10.1007/s11255-015-1004-2. Epub 2015 May 14. Int Urol Nephrol. 2015. PMID: 25971352
-
An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory.Mol Med. 2024 May 26;30(1):71. doi: 10.1186/s10020-024-00824-9. Mol Med. 2024. PMID: 38797859 Free PMC article. Review.
-
Levels of soluble cell adhesion molecules in type 2 diabetes mellitus patients with macrovascular complications.J Int Med Res. 2020 Apr;48(4):300060519893858. doi: 10.1177/0300060519893858. Epub 2019 Dec 29. J Int Med Res. 2020. PMID: 31885308 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous